EFFICACY OF THE DUPILUMAB 200 MG DOSE EVERY 2 WEEKS IN CHILDREN WITH MODERATE-TO-SEVERE ASTHMA DURING VOYAGE AND EXCURSION

被引：0
|
作者：
Phipatanakul, W. [1 ]
Vogelberg, C. [2 ]
LB, Bacharier [3 ]
Dell, S. D. [4 ]
Altincatal, A. [5 ]
Gall, R. [6 ]
Ledanois, O. [7 ]
Sacks, H. [6 ]
Jacob-Nara, J. A. [8 ]
Deniz, Y. [6 ]
Rowe, P. J. [8 ]
机构：
[1] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA
[2] Techn Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
[3] Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, Med Ctr, Nashville, TN USA
[4] BC Childrens Hosp, Vancouver, BC, Canada
[5] Sanofi, Cambridge, MA USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Sanofi, Paris, France
[8] Sanofi, Bridgewater, NJ USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO26
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [1] Efficacy of dupilumab 200 mg every 2 weeks in children with moderate-to-severe asthma: A post hoc analysis of voyage and excursion
    Phipatanakul, W.
    Jackson, D.
    Vogelberg, C.
    Bacharier, L.
    Dell, S. D.
    Altincatal, A.
    Gall, R.
    Ledanois, O.
    Sacks, H.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    ALLERGY, 2023, 78 : 265 - 265
  • [2] Dupilumab Efficacy and Safety in Children with Uncontrolled, Moderate-to-Severe Asthma: The Phase 3 VOYAGE Study
    Bacharier, L. B.
    Maspero, J. F.
    Katelaris, C. H.
    Fiocchi, A. G.
    Gagnon, R.
    de Mir, I
    Jain, N.
    Sher, L. D.
    Mao, X.
    Liu, D.
    Zhang, Y.
    Khan, A. H.
    Kapoor, U.
    Khokhar, F. A.
    Rowe, P.
    Deniz, Y.
    Ruddy, M.
    Laws, E.
    Amin, N.
    Mannent, L. P.
    Lederer, D. J.
    Hardin, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [3] Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study
    Guilbert, Theresa W.
    Tolcachier, Alberto
    Fiocchi, Alessandro G.
    Katelaris, Constance H.
    Phipatanakul, Wanda
    Begin, Philippe
    de Mir, Ines
    Altincatal, Arman
    Gall, Rebecca
    Ledanois, Olivier
    Radwan, Amr
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 143 - 159
  • [4] Dupilumab Improves Lung Function in Children With Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE
    Bacharier, B. L.
    Guilbert, W. T.
    Katelaris, H. C.
    Deschildre, A.
    Liu, D.
    Mannent, P. L.
    Amin, N.
    Laws, E.
    Ruddy, M.
    Ortiz, B.
    Jacob-Nara, A. J.
    Deniz, Y.
    Rowe, J. P.
    Atenhan, A.
    Thakur, M.
    Lederer, J. D.
    Hardin, M.
    PNEUMOLOGIE, 2022, 76 : S40 - S40
  • [5] Dupilumab Improves Lung Function in Children with Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE
    Bacharier, L. B.
    Guilbert, T. W.
    Katelaris, C. G.
    Deschildre, A.
    Liu, D.
    Mannent, L. P.
    Laws, E.
    Ruddy, M.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    Lederer, D. J.
    Hardin, M.
    PEDIATRIC PULMONOLOGY, 2022, 57 : S97 - S98
  • [6] DUPILUMAB IMPROVES LUNG FUNCTION IN CHILDREN WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: LIBERTY ASTHMA VOYAGE
    Bacharier, Leonard
    Guilbert, Theresa
    Katelaris, Constance
    Deschildre, Antoine
    Liu, Dongfang
    Mannent, Leda
    Amin, Nikhil
    Laws, Elizabeth
    Ruddy, Marcella
    Ortiz, Benjamin
    Jacob-Nara, Juby
    Deniz, Yamo
    Rowe, Paul
    Lederer, David
    Hardin, Megan
    CHEST, 2021, 160 (04) : 1885A - 1887A
  • [7] Dupilumab Efficacy in Children with Uncontrolled, Moderate-to-severe Type 2 Asthma, with and Without Evidence of Allergic Asthma in the VOYAGE Phase 3 Study
    Papadopoulos, Nikolaos G.
    Szefler, Stanley J.
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Domingo, Christian
    Daizadeh, Nadia
    Lederer, David J.
    Hardin, Megan
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Gall, Rebecca
    Ortiz, Benjamin
    Djandji, Michel
    Rowe, Paul J.
    PEDIATRICS, 2022, 149 (01)
  • [8] Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Katelaris, Constance H.
    Fiocchi, Alessandro G.
    Gagnon, Remi
    de Mir, Ines
    Jain, Neal
    Sher, Lawrence D.
    Mao, X.
    Liu, D.
    Zhang, Yi
    Khan, Asif H.
    Kapoor, Upender
    Khokhar, Faisal A.
    Rowe, Paul J.
    Deniz, Yamo
    Ruddy, Marcella
    Laws, Elizabeth
    Patel, Naimish
    Weinreich, David M.
    Yancopoulos, George D.
    Amin, Nikhil
    Mannent, Leda P.
    Lederer, David J.
    Hardin, Megan
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24): : 2230 - 2240
  • [9] Dupilumab efficacy in children with uncontrolled, moderate-to-severe type 2 asthma, with and without evidence of allergy, in the phase 3 VOYAGE study
    Papadopoulos, N. G.
    Szefler, S. J.
    Bacharier, L. B.
    Maspero, J. F.
    Domingo, C.
    Daizadeh, N.
    Lederer, D. J.
    Hardin, M.
    Jacob-Nara, J. A.
    Deniz, Y.
    Gall, R.
    Ortiz, B.
    Djandji, M.
    Rowe, P.
    ALLERGY, 2021, 76 : 175 - 176
  • [10] Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
    Castro, M.
    Corren, J.
    Pavord, I. D.
    Maspero, J.
    Wenzel, S.
    Rabe, K. F.
    Busse, W. W.
    Ford, L.
    Sher, L.
    FitzGerald, J. M.
    Katelaris, C.
    Tohda, Y.
    Zhang, B.
    Staudinger, H.
    Pirozzi, G.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Martincova, R.
    Graham, N. M. H.
    Hamilton, J. D.
    Swanson, B. N.
    Stahl, N.
    Yancopoulos, G. D.
    Teper, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26): : 2486 - 2496
12345